68Ga-DOTATATE ( DrugBank: 68Ga-DOTATATE, Dotatate )

3 diseases

75. クッシング病

臨床試験数 : 203 / 薬物数 : 191 - (DrugBank : 51) / 標的遺伝子数 : 62 - 標的パスウェイ数 : 128

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02019706 (ClinicalTrials.gov)	February 12, 2014	21/12/2013	Evaluation of 68Ga-DOTATATEPET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushin ...	Evaluation of 68Ga-DOTATATEPET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushin ...	ACTH;Cushing's Syndrome	Radiation: DOTATATE PET-CT;Radiation: F-DOPA PET CT;Radiation: CT scan;Diagnostic Test: Routine MRI ...	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Recruiting	18 Years	80 Years	All	80	Phase 2	United States

臨床試験数 : 149 / 薬物数 : 227 - (DrugBank : 81) / 標的遺伝子数 : 82 - 標的パスウェイ数 : 167

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03549598 (ClinicalTrials.gov)	July 20, 2018	25/5/2018	d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis	d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis	Cardiac Sarcoidosis	Drug: 68Ga-DOTATATE PET/CT;Drug: 18FDG PET/CT scan;Drug: 13NH3 PET/CT scan	Mayo Clinic	NULL	Completed	18 Years	N/A	All	15	Phase 4	United States

臨床試験数 : 29 / 薬物数 : 25 - (DrugBank : 11) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 20

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03736564 (ClinicalTrials.gov)	January 31, 2019	30/10/2018	Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia	68Ga-DOTATATEPET for Localization of Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced ...	Osteomalacia	Combination Product: 68Ga-DOTATATE PET/CT	Mayo Clinic	NULL	Recruiting	18 Years	N/A	All	10	Phase 1/Phase 2	United States